ImmunoGen
ImmunoGen
Employees:
300
Market Cap:
$673.35 million
Revenue:
$115.23 million
5 Year Trend:
42.6%
Net Income:
$-108.29 million
Stock:
IMGN

ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. Wikipedia

ImmunoGen
Are you from ImmunoGen?

ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. Wikipedia

Employees:
300
Market Cap:
$673.35 million
Revenue:
$115.23 million
5 Year Trend:
42.6%
Net Income:
$-108.29 million
Stock:
IMGN

17 jobs at ImmunoGen

Jobs in